Background-Several studies have demonstrated a high accuracy of coronary computed tomography angiography (CCTA) for detection of obstructive coronary artery disease (CAD), whereas some studies have also shown a good prediction of cardiac events. However, it remains to be proven whether CCTA is better predictive of events than conventional risk scores or calcium scoring. Therefore, we compared CCTA with calcium scoring and clinical risk scores for the ability to predict cardiac events. Methods and Results-Patients (nϭ2223) with suspected CAD undergoing CCTA were followed up for a median of 28 months. The end point was the occurrence of cardiac events (cardiac death, nonfatal myocardial infarction, unstable angina requiring hospitalization, and coronary revascularization later than 90 days after CCTA). Patients with obstructive CAD had a significantly higher event rate (2.9% per year; 95% confidence interval, 2.1 to 4.0) than those without obstructive CAD, having an event rate 0.3% per year (95% confidence interval, 0.1 to 0.5; hazard ratio, 13.5; 95% confidence interval, 6.7 to 27.2; PϽ0.001). CCTA had significant incremental predictive value when compared with calcium scoring, both with scores assessing the degree of stenosis (PϽ0.001) and with scores assessing the number of diseased coronary segments (Pϭ0.027). Conclusions-In patients with suspected CAD, CCTA not only detects coronary stenosis but also improves prediction of cardiac events over and above conventional risk scores and calcium scoring. This may result in a reclassification of cardiovascular risk in a substantial proportion of patients. (Circ Cardiovasc Imaging. 2011;4:16-23.)
I
n recent years, coronary computed tomography angiography (CCTA) has emerged as a new noninvasive imaging modality for the assessment of coronary artery disease (CAD) . Multiple studies demonstrated a high diagnostic accuracy of CCTA for the detection and the exclusion of coronary stenoses of CCTA when compared with invasive coronary angiography. 1 However, data regarding the prognostic value of CCTA for clinical cardiac events are only beginning to emerge. [2] [3] [4] [5] [6] [7] [8] [9] Clinical Perspective on p 23
CCTA has the unique advantage of not only depicting the vessel lumen but also the surrounding tissue noninvasively in 3 dimensions and with a high spatial resolution. Therefore, CCTA can easily detect nonobstructive calcified and noncalcified plaques as well as plaques with positive remodeling, both of which play important roles in the pathophysiology of acute myocardial infarction and may be indicative of vulnerable plaques. 10 Nevertheless, established scores describing these "vulnerable" plaques or evaluating the total atherosclerotic disease burden do not exist.
Besides clinical risk scores, calcium scoring is a wellestablished and extensively validated imaging modality for assessing cardiovascular risk. 11, 12 Up to now, only limited data exist comparing the prognostic value of data derived from CCTA with this more established modality. 9 The aims of this study were to evaluate the prognostic value of CCTA in a large otherwise unrestricted group of patients with suspected CAD and evaluate the additional value of different CCTA scores assessing coronary stenosis and/or plaques over clinical risk predictors and calcium scoring on cardiac events.
Methods

Study Population
The present study is based on all consecutive patients with suspected but not prior proven CAD undergoing both CCTA and calcium scoring during the same procedure in our institution between December 1, 2003, and November 30, 2008 . Only patients without stable sinus rhythm during examination and patients in acute life-threatening conditions were excluded from analysis. Written informed consent was obtained from all patients before examination.
A structured interview was performed before examination, and information about age, patient height and weight, history of cardiac disease, present concerns, and current medication was collected. In addition, laboratory tests for total cholesterol, LDL and HDL fractions, and triglycerides were performed. From these data, the Framingham risk score assessing the 10-year risk for symptomatic CAD with the established categorical model using LDL-cholesterol according to Wilson et al 13 and the Morise pretest score were calculated. 14 The Morise score was also used to assess the pretest risk for CAD. The study design was approved by the local ethics committee.
Image Acquisition and Analysis
Images for calcium scoring were acquired by a non-contrastenhanced sequential scan and analyzed with a commercially available software package (Siemens Calcium Score, Siemens, Erlangen, Germany) using the Agatston score with a cutoff of 130 HU. For CCTA, a bolus-timing test scan using 10 to 20 mL of contrast (Iomeprol, Imeron 350, Bracco Altana Pharma GmbH, Konstanz, Germany; iodine content, 350 mg/mL) followed by a 50-mL saline chaser was used. After administration of 80 to 140 mL of contrast individually adjusted to the selected table feed and scan range at a rate of 4 to 6 mL/s followed by a 50-mL saline chaser, the CCTA images were acquired. ECG-gated tube current modulation was used in patients with stable sinus rhythm for reduction of radiation dose exposure. Different CT system configurations were used during the study period: A 16- 16 and assuming a linear correlation between radiation dose and risk.
For image analysis, the coronary artery tree was segmented according to the modified American Heart Association classification. 17 Each segment with a diameter Ͼ1.5 mm was evaluated by 2 experienced readers (1 radiologist and 1 cardiologist, both having read Ͼ500 cardiac CT studies). Any disagreement was settled by consensus. The degree of stenosis was rated visually using 4 groups: no relevant stenosis (Ͻ25%), mild (25% to 49%), moderate (50% to 74%), and severe (Ն75%) stenosis. If a moderate or severe stenosis could not be excluded because of artifacts, the segment was classified as having a moderate stenosis. Obstructive CAD was defined as at least 1 segment having a stenosis of Ն50%. In addition, for each segment, the presence of calcium and the presence of noncalcified plaques were assessed. Plaques showing both noncalcified and calcified areas were classified as mixed plaques. A test for interobserver variation on a subpopulation was published previously 18 and showed a Cohen for coronary obstruction of 0.84 on a per artery basis and 0.76 on a per-segment basis.
Coronary Obstruction Score
From the primary analysis, these CCTA scores were calculated: Coronary obstruction score was obtained by counting the most significant plaque or stenosis of any segment; score 0, all coronary segments Ͻ25% and without any plaques; score 1, at least 1 coronary segment with nonobstructive plaques (Ͻ25% stenosis); score 2, at least 1 coronary segment with mild stenosis (25% to 49%); score 3, at least 1 coronary segment with moderate stenosis (50% to 74%); and score 4, at least 1 coronary segment with severe stenosis (Ն75%).
Number of Involved Segments
The number of segments with any stenosis Ն25% or any calcified, mixed, or noncalcified plaques, irrespective of the degree of stenosis, was calculated.
In addition, the noncalcified, mixed, and calcified plaque burden, defined as the number of coronary segments with noncalcified, mixed, or calcified plaques irrespective of stenosis, was calculated.
Presence of Left Proximal Lesion
A binary variable indicating a stenosis Ն25% in the left main or proximal left anterior descendent coronary artery was used.
Published Scores
For comparison, 2 recently published scores were calculated: The Severity of CAD Score proposed by Chow et al 19 with the categories "normal," "nonobstructive," "low-risk obstructive," and "high-risk obstructive" and the segment stenosis score combining number and extend of stenoses proposed by Min et al. 3 
Follow-Up and Study End Point
Follow-up information was gathered by clinical visits, telephone contact, or questionnaire sent by mail. We verified all reported events by hospital records or contacts with the attending physician.
The end point of the study was the occurrence of cardiac events defined as cardiac death (including any death without definitive noncardiac cause), nonfatal myocardial infarction, or unstable angina pectoris requiring hospitalization or coronary revascularization, whatever occurred first. Nonfatal myocardial infarction was defined based on the criteria of typical acute chest pain and persistent ST-segment elevation or positive cardiac enzymes. Unstable angina pectoris was defined according to the ESC guidelines 20 as typical acute chest pain with negative cardiac enzymes if CAD could not be excluded as the cause of symptoms. Death from clearly noncardiac cause was not counted as event. Patients undergoing coronary revascularization within 90 days after CCTA were censored at the time of intervention (and excluded from further analysis) because these interventions were performed in the context of an invasive angiography, which was recommended because of abnormal CCTA.
Statistical Analysis
Categorical variables were expressed as frequencies and percentages, and continuous variables were expressed as median [25th percentile (Q1), 75th percentile (Q3)]. All statistical evaluations are based on the event-free survival for the study end point using the KaplanMeier method; hazard ratios (for difference between 75th and 25th percentile) and multivariable analyses were calculated with the Cox proportional hazard model. C-indices were calculated from time-toevent data, for correlations the spearman test was used. The incremental predictive value was assessed primarily using the Integrated Discrimination Improvement (IDI) method according to Pencina et al 21 ; for comparison, the results of conventional c-statistics were also given. Statistical significance was accepted for 2-sided probability values Ͻ0.05. The statistical package R version 2.10.1 22 including the package Design 23 was used for statistical analysis.
Results
Study Population
Patients (nϭ2387) with suspected CAD underwent both CCTA and calcium scoring during the study period. Of these, 6 patients with acute aortic dissection undergoing CCTA for preoperative assessment of CAD and 62 patients without stable sinus rhythm during investigation were excluded. Of the remaining 2319 patients, 2223 could be contacted for follow-up, resulting in a follow-up rate of 95.9%. Duration of follow-up ranged from 7 to 64.8 months, with a median of 29 months (Q1, 17 months; Q3, 42 months).
Clinical Characteristics
The median age of the patients was 60 years (Q1, 52 years; Q3 67 years), and 1486 patients (66.8%) were male. The majority of patients were characterized with a low to intermediate pretest risk for CAD according to Morise score. Detailed patient characteristics are summarized in Table 1 .
In the group of patients lost on follow-up, the mean age was significantly lower (median, 54 years [Q1, 46 years; Q3, 63 years], PϽ0.001). Together with a lower prevalence of arterial hypertension (48% versus 59%, Pϭ0.04) this led to a significant lower pretest risk as assessed by Morise score (10 versus 11, Pϭ0.008). The other clinical characteristics showed no significant difference.
Results of CCTA
CCTA revealed completely normal coronary arteries in 538 patients (24.2%); 1052 patients (47.3%) had nonobstructive CAD and 633 patients (28.5%) were classified as having obstructive CAD. Of 1595 patients (71.7%) with plaques on CCTA, 1021 patients had noncalcified plaques involving up to 9 segments, 642 patients had mixed plaques involving up to 8 segments, and 1168 patients had calcified plaques involving up to 12 segments. On calcium scoring, 1400 patients (63.0%) showed calcifications resulting in a median Agatston score of 11.6 (Q1, 0; Q3, 141). A detailed summary of the CT results is provided in Table 2 .
Several CCTA indices were highly correlated, in particular, the coronary obstruction score, the number of involved segments, the severity of CAD score, and the segment stenosis score (all Ͼ0.80). Calcium scoring correlated with the number of involved segments and the number of calcified plaques (both ϭ0.85). The median radiation dose exposure associated with the investigation was 7.4 mSv (Q1, 4.8 mSv; Q3, 9.2 mSv) for CCTA and 0.8 mSv (Q1, 0.8 mSv; Q3, 0.9 mSv) for calcium scoring, equivalent to an estimated lifetimeattributable risk for lung cancer of 1:3000 for CCTA and 1:26 000 for calcium scoring.
Cardiac Events
Not counting early revascularizations, we observed 47 cardiac events: 4 cardiac deaths, 8 patients with nonfatal myocardial infarctions (of which 2 had ST-segment elevation myocardial infarction), 4 patients with unstable angina pectoris requiring hospitalization, and 31 patients undergoing late coronary revascularizations because of stable angina pectoris after 16 months in median (Q1, 10 months; Q3, 33 months). The overall event rate was 0.9% per year (95% confidence interval [CI], 0.7 to 1.2).
Comparison Between Different CCTA Scores
Looking at the coronary obstruction score in detail, the annual event rate ranged from 0% for patients with completely normal Figure 1 . Annual cardiac event rate plotted against the coronary obstruction and segment involvement score. coronaries to 4.2% (95% CI, 2.0 to 8.8) for patients with stenoses Ͼ75%. Patients with obstructive CAD had a significantly higher event rate (2.9% per year; 95% CI, 2.1 to 4.0) than those without obstructive CAD, having an event rate 0.3% per year (95% CI, 0.1 to 0.5; hazard ratio, 13.5; 95% CI, 6.7 to 27.2, PϽ0.001). The annual event rate increased with the extent of coronary involvement as well, ranging from 0% for no involvement to 4.9% (95% CI, 2.6 to 9.0) for more than 9 segments Values are expressed as occurrence (percentage) or median ͓25th, 75th percentile͔ both in the group of patients with and without cardiac events. Hazard ratio is given with 95% CI and calculated between 75th and 25th percentiles.
involved (Figures 1 and 2 , and Table 3 ). All CCTA scores had incremental predictive value over Morise score (all PϽ0.001). The results were different for the comparison with calcium score, which carried incremental predictive value over Morise score itself (PϽ0.001): Both the coronary obstruction score (PϽ0.001) and the number of involved segments (Pϭ0.027) as well as the published scores from Min and Chow (Pϭ0.013 and PϽ0.001 respectively, all probability values for IDI statistics) had statistically significant additional predictive value, whereas a separate analysis of the different plaques types or of lesions in the proximal left coronary artery yielded no significant additional value (see also Table 4 ).
Analyzing the incremental value of calcium score and CCTA, the predictive value of Morise score (c-index, 0.76) could be increased by the calcium score (c-index, 0.84 for the combined model; PϽ0.001). By further adding the coronary obstruction score, the c-index of the combined model increased significantly to 0.89 (PϽ0.001), and by adding the number of involved segments to calcium and Morise score, the c-index of the combined model increased significantly to 0.85 (Pϭ0.027). Figure 3 depicts the results of this analysis.
Reclassification of Cardiovascular Risk
To demonstrate the additional value of CCTA in a plain classification model, we took the 3 risk categories of Morise risk score as indicator for the pretest risk and used the presence of obstructive CAD by CCTA as an additional risk predictor. With this approach, a considerable number of Improvement of risk prediction compared with a base model consisting of Morise clinical risk score and calcium (Agatston) score, expressed both as increase of c-index and relative integrated discrimination improvement.
patients could be reclassified regarding their risk for future cardiac events. Using a risk stratification of low risk defined as an event rate of Ͻ1% per year and high risk as an event rate of Ͼ2% per year, 433 patients had a low pretest risk with a yearly event rate of 0%. From the 1645 patients having an intermediate pretest risk with a yearly event rate of 1.0%, the 1145 patients (70%) having no obstructive CAD had a yearly event rate of 0.3%, whereas those with obstructive CAD had a yearly event rate of 3.2%. In the small patient group with a high pretest risk (145 patients with a yearly event rate of 3.8%), the 66 patients without obstructive CAD had a low event rate of 0.5%, whereas the event rate of the patients with obstructive CAD was 11.8%. This resulted in a reclassification of 1711 patients (70%); 1211 patients (54%) could be reassigned to have a lower risk, whereas 500 (22%) were reassigned to a higher risk for cardiac events. The relative improvement of risk prediction according to IDI statistics was 155% (PϽ0.001; Figure 4 ).
Discussion
The key findings of this study are (1) The exclusion of obstructive CAD by CCTA is associated with a very low cardiac event rate well below 1% per year, whereas the event rate of patients with obstructive CAD is significantly higher, at approximately 3% per year. (2) Both CCTA scores taking into account the degree of stenosis and those assessing the extent of atherosclerosis can predict cardiac events significantly better than calcium scoring and clinical risk scores. (3) This could result in a reclassification of cardiovascular risk in a substantial proportion of patients, particularly in those at intermediate pretest risk according to Morise risk score.
A unique advantage of CCTA is the ability not only to visualize the coronary lumen in high resolution but also to detect calcified and noncalcified coronary plaques. By detection of stenoses as well as calcified and noncalcified plaques, the real burden of CAD is assessable by CCTA. Several retrospective studies could demonstrate that the majority of myocardial infarctions have the origin in previously nonobstructive lesions. 24 -26 As a consequence, one would expect that scores measuring the overall coronary burden of atherosclerotic disease disregarding the stenosis have a particularly strong prognostic value. However, this could not be demonstrated in our study. Best performed those scores that considered the degree of stenosis like the coronary obstruction score. Similar results were described by Gaemperli et al, 6 who found that the presence of at least 1 obstructive stenosis had the best sensitivity, Ostrom et al, 7 who identified the severity of CAD score as the best predictor with an significant increased risk for 3-vessel nonobstructive CAD and any type of obstructive CAD, and Chow et al, 19 who found a significantly increased risk of major cardiac events in obstructive CAD only. In our study, we found a good predictive value for the number of involved segments measuring only the extent of atherosclerotic disease that nevertheless was not better than the scores taking into account the degree of stenosis. This finding somehow stands in contrast with other studies demonstrating a particularly good predictive value for scores assessing the extent of CAD. 2, 3 Although the end point of this study that comprises late revascularizations might favor stenosis-dependent scores, Punziute et al 2 demonstrated the good performance of plaque scores on an end point comprising all revascularizations. Nevertheless, the performance of the different scores depends highly on the patient population. In our low-to intermediate-risk study cohort, the prevalence of obstructive CAD was 18% and in the same range as in the study of Ostrom et al, 7 whereas in most other studies the prevalence was much higher, ranging from 32% 2 up to 43%. 6 A further plaque characterization in noncalcified, mixed, or calcified plaques did not yield any additional information in our study. A more elaborate plaque characterization might yield additional information, as described by Motoyama et al. 27 Nevertheless, the c-indices presented in his study (ranging from 0.70 to 0.84) were not better than the best of the above-mentioned scores. All these findings add further evidence to the fact that in prospective studies, the degree of stenosis does matter for prognosis. 28 The key question to any prognostic tool is how it improves conventional risk scores. CCTA must compete here with calcium scoring, a well-established and validated imaging modality for cardiac risk stratification. 11, 12 Both the coronary obstruction score and the number of involved segments in CCTA significantly improved the predictive value of calcium scoring and clinical risk factors. Of note is the fact that this improvement is caused mainly by an increased specificity, as can be seen in the marked difference of the receiver operator curves in the left lower part of Figures 3C and 3D . In the clinical work flow, CCTA adds substantial prognostic information to clinical risk scores, particularly in the largest group of patients being at an intermediate pretest risk. This patient group could be reassigned to having either a very low risk below 1% per year or a considerable risk of above 3% per year for a major cardiac event. In addition, a similar discrimination is also possible in patients with high pretest risk: nearly two thirds of patients with high risk could be reassigned to a lower-risk group. Further studies on the prognostic value of CCTA in these patient groups might be promising.
In a recently published study, 29 we demonstrated the predictive value of obstructive CAD by CCTA in a subgroup of this study population. The limited number of patients allowed only for an estimation of the additional value above clinical risk predictors and prevented a comparison with calcium scoring. By increasing both patient number and follow-up time, we could now overcome these shortcomings and clearly demonstrate the incremental value of CCTA when compared with calcium scoring and clinical risk scores.
In the current study, the radiation dose associated with CCTA was 9 times higher than that of calcium scoring resulting in a lifetime-attributable risk for lung cancer of 1:3000. The gain in prognostic information must be weighted against this risk. Nevertheless, in the meantime, the radiation dose associated with CCTA has decreased significantly as the result of new dose-saving algorithms, allowing for a reduction of the radiation exposure below 1 mSv. 30 This would correspond to a lifetime-attributable risk of lung cancer below 1:20 000.
The overall event rate is quite low and prevents a robust analysis of serious cardiac events (cardiac death and nonfatal myocardial infarction), although this would be of great interest. This is a direct consequence of the unselected population enrolled in this study. Except for patients with acute life-threatening conditions and patients with arrhythmias preventing valid CCTA evaluation, we included all consecutive patients with suspected CAD.
There might be a bias in favor of the scores assessing coronary obstruction because the decision for revascularization is based among others on the degree of stenosis. We minimized this effect by excluding all early revascularizations from the analysis, but an overestimation of the stenosis-based scores cannot be excluded. Nevertheless, the incremental value of the number of involved segments in CCTA above calcium score is not affected by this limitation because both scores measure plaque burden only. This is an observational study, and the result of the CCTA study guided further treatment. We reduced the impact of those effects by excluding coronary revascularizations occurring within 90 days of investigation from risk analysis. Furthermore, valid information regarding changes in lifestyle or in medication after the CCTA study is not available. For a thorough validation of the method, multicenter randomized outcome trials are warranted.
In patients with suspected CAD, CCTA has a significant prognostic impact not only for the identification of obstructive CAD but also for the prediction of cardiac events. By a clear differentiation between patients of high and low risk both by scores assessing the degree of stenosis and the extent of atherosclerosis, CCTA adds significant prognostic information to clinical risk scores and calcium scoring. In addition to the diagnostic value of stenosis detection, CCTA may therefore improve the cardiac risk prediction for patients in whom CAD cannot be ruled out clinically.
